MedTrace Logo

The EMBER Trial for Weight Management Engagement

NCT05424081 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 470

Last updated 2026-05-22

Study results available
· View outcomes & findings →

Summary

This study will test whether EMBER, a self-help tool to increase weight loss treatment engagement, helps veterans engage in Veterans Health Administration (VHA) weight management programs. Participants will be randomly assigned to receive EMBER or a list of weight management programs (the control group). They will answer questions about health beliefs and behaviors and share information from their medical record at the start of the study, 2-months after the start of the study, and 6-months after the start of the study. Participants will receive compensation for each of these contacts. Participants will also receive a reminder call 10 days after they enroll in the study. All study contacts will be over the phone. The main hypothesis is that people who receive EMBER will be more likely to use VHA weight management programs than people in the control group.

Conditions

Interventions

BEHAVIORAL

EMBER

Self-help tool to increase weight management engagement

BEHAVIORAL

Control

List of weight management programs

Sponsors & Collaborators

  • VA Office of Research and Development

    lead FED

Principal Investigators

  • Jessica Yelena Breland, PhD MS BA · VA Palo Alto Health Care System, Palo Alto, CA

Study Design

Allocation
RANDOMIZED
Purpose
HEALTH_SERVICES_RESEARCH
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
79 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2022-09-19
Primary Completion
2024-11-29
Completion
2025-03-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05424081 on ClinicalTrials.gov